However, patients enrolled from TCGA HNSCC cohort have received anti-tumor therapies, and these results indicated that high expression of TNF family members could have better therapeutic responses, thus leading to a better overall survival. The gene discussed is TNF; the disease is head and neck squamous cell carcinoma.